Masimo Corp. Files 8-K Amendment
Ticker: MASI · Form: 8-K · Filed: Sep 29, 2025 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | 8-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, filing
Related Tickers: MASI
TL;DR
Masimo Corp. filed an 8-K amendment, likely correcting or adding info to a prior filing.
AI Summary
Masimo Corp. filed an 8-K/A amendment on September 29, 2025, related to events on September 23, 2025. The filing is an amendment to a previous 8-K report and concerns financial statements and exhibits.
Why It Matters
This filing is an amendment to a previous report, indicating a potential correction or addition to previously disclosed information by Masimo Corp.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, not indicating new material events or financial distress.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- 0000937556-25-000151 (filing_id) — Accession Number
- September 23, 2025 (date) — Earliest event reported
- September 29, 2025 (date) — Date of report
- 52 Discovery Irvine, CA 92618 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment to a previous Form 8-K, intended to correct or supplement information previously reported.
What is the date of the earliest event reported in this filing?
The earliest event reported is dated September 23, 2025.
When was this 8-K/A filing submitted to the SEC?
The filing was submitted on September 29, 2025.
What is the principal business address of Masimo Corp?
The principal executive offices are located at 52 Discovery, Irvine, CA 92618.
What is the SIC code for Masimo Corp?
The Standard Industrial Classification (SIC) code for Masimo Corp is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 840 words · 3 min read · ~3 pages · Grade level 14.9 · Accepted 2025-09-29 16:18:36
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value MASI The Nasdaq Stock Market
Filing Documents
- masi-20250923.htm (8-K) — 36KB
- masi-20250929xex991.htm (EX-99.1) — 272KB
- masi-20250923_g1.jpg (GRAPHIC) — 199KB
- 0000937556-25-000151.txt ( ) — 918KB
- masi-20250923.xsd (EX-101.SCH) — 2KB
- masi-20250923_def.xml (EX-101.DEF) — 15KB
- masi-20250923_lab.xml (EX-101.LAB) — 26KB
- masi-20250923_pre.xml (EX-101.PRE) — 15KB
- masi-20250923_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (b) Pro Forma Financial Information. The following unaudited pro forma financial information of the Company is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 28, 2025, Unaudited Pro Forma Condensed Consolidated Statement of Operations for each of the fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022, and Notes to the Unaudited Pro Forma Condensed Consolidated Financial Statements. The Unaudited Pro Forma Condensed Consolidated Balance Sheet of the Company dated as of June 28, 2025, included in Exhibit 99.1, gives effect to the Disposition Adjustments and Other Transaction Adjustments described therein as if they had occurred or become effective on June 28, 2025. The Unaudited Pro Forma Condensed Consolidated Statements of Operations for the years ended December 28, 2024, December 30, 2023 and December 31, 2022, which are also included in Exhibit 99.1, give effect to the Disposition Adjustments and Other Transaction Adjustments as if they had occurred or become effective on January 2, 2022, the beginning of the earliest period presented. (d) Exhibits The following items are filed as exhibits to the Current Report on Form 8-K. Exhibit No. Description 99.1 Unaudited Pro Forma Condensed Consolidated Financial Statements of Masimo 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Masimo Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MASIMO CORPORATION Date: September 29, 2025 By: /s/ M ICAH Y OUNG Micah Young Executive Vice President & Chief Financial Officer (Principal Financial Officer)